City
Epaper

Amid vaccine certification issue, National Health Authority CEO calls for deepening India-UK health ties

By ANI | Updated: September 23, 2021 20:10 IST

After meeting British High Commissioner to India Alex Ellis here, National Health Authority's CEO Dr RS Sharma has said that he looks forward to deepening ties between the health bodies of the two countries.

Open in App

After meeting British High Commissioner to India Alex Ellis here, National Health Authority's CEO Dr RS Sharma on Thursday said that he looks forward to deepening ties between the health bodies of the two countries.

The meeting came amid the rising concerns over the new travel rules issued by the UK.

Dr Sharma said that the meeting will be instrumental in resuming socio-economic ties between the two countries.

"Echoing his excellency @AlexWEllis's views, this will be instrumental in resuming socio-economic activities between India and UK. We also look forward to deepening ties between @AyushmanNHA and @NHSX, as we collaborate to build a digital continuum of healthcare services," Dr Sharma said in a tweet.

Earlier, Ellis said the "excellent discussions" were an important step forward in "our joint aim to facilitate travel and fully protect the public health of UK and India".

"Excellent technical discussions with @rssharma3 @AyushmanNHA. Neither side raised technical concerns with each other's certification process. An important step forward in our joint aim to facilitate travel and fully protect public health of UK and India," Ellis tweeted.

The UK issued a revised travel advisory on Wednesday and said that Covishield is qualified as an approved vaccine.

It approved individuals with a full course of the Oxford-AstraZeneca, Pfizer BioNTech, Moderna or Janssen vaccines from a relevant public health body in Australia, Antigua and Barbuda, Barbados, Bahrain, Brunei, Canada, Dominica, Israel, Japan, Kuwait, Malaysia, New Zealand, Qatar, Saudi Arabia, Singapore, South Korea or Taiwan. But the list does not include India. This advisory will be applicable from 4 am (local time) on October 4.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: National Health AuthorityPfizerAyushman national health authorityPfizer inc.Pfizer india
Open in App

Related Stories

NationalHow to Claim the Cashless Treatment Scheme for Road Accident Victims

InternationalFormer Pfizer Employee, Indian-American, Found Guilty of Insider Trading on Covid Medicine Trial in the US

InternationalEx-Pfizer employee, accomplice from India charged with insider trading in US

BusinessFormer Pfizer employee charged with insider trading

HealthStudy finds cancer cells can adapt to novel drugs

International Realted Stories

InternationalUS intensifies de-escalation efforts, Marco Rubio speaks to Pak FM, Army Chief and EAM Jaishankar

InternationalUS Secretary of State speaks with EAM Jaishankar, proposes US support for "productive discussions" with Pakistan

InternationalMarco Rubio reaches out to real centre of Pakistan power, talks to army chief

International"Pakistani claims continue to be heavy on lies, misinformation, propaganda," FS slams Pakistan's misinformation campaign

International"Closely following ongoing situation, deeply concerned", says China on escalating tensions between India, Pakistan